Soulpower Acquisition Corp.
NYSE:SOULShell Companies
+$0.00 today
- Market cap
- $270.29M
- Beta
- 0.05
- P/E (TTM)
- 34.3
- EPS (TTM)
- $0.30
Volume 0.10M
Average 0.02M
SOUL Total Non-current Liabilities
All obligations due after more than one year.
Soulpower Acquisition Corp.NYSE: SOUL
Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total non-current liabilities rises 4602.5% from a year ago
Total non-current liabilities stood at $10.6M at the end of Q1 FY2026, up 4602.5% from a year earlier and up 0.0% from the prior quarter.
Context
- Total non-current liabilities amounted to 4.0% of total assets at the end of Q1 FY2026, down 359.8 pp from a year earlier.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +4602.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 10.6M USD
- Year-over-year change
- +8497.3%
- 1-year CAGR
- +8497.3%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.6M | +8497.3% |
| FY2024 | 2024-12-31 | 123.3K | — |
Total Non-current Liabilities vs competitors
How SOUL compares with its peers on the latest reported figures
- SOUL's Mar 2026 total non-current liabilities of $10.6M is the 3rd highest of the 8 companies compared; the peer median is $8.94M.
- Its year-over-year change of +4602.5% is the 2nd highest of 6, against a peer median of +0.0%.
- Total non-current liabilities amounts to 4.0% of total assets for SOUL, versus a peer median of 3.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $13.14M | — | — | 4.6% | |
AACBArtius II Acquisition Inc. Class A Ordinary Shares | Mar 2026 | $12.6M | +0.0% | — | 5.5% |
| Mar 2026 | $10.6M | +4602.5% | — | 4.0% | |
| Mar 2026 | $9.38M | +17.3% | +15.1% | 5.0% | |
| Mar 2026 | $8.94M | +15731514084507043840.0% | — | 3.6% | |
| Mar 2026 | $8.05M | +0.0% | — | 3.3% | |
OACCOaktree Acquisition Corp. III Life Sciences | Mar 2026 | $7.02M | +0.0% | — | 3.4% |
| Mar 2026 | $6.9M | — | — | 3.8% | |
| Peer median (excluding SOUL) | $8.94M | +0.0% | +15.1% | 3.8% | |
Competitors are the stored peer set for SOUL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 25.39K | 207.11K |
| Short-term Investments | 0 | 0 |
| Net Receivables | 0 | 1.19M |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | 0 |
| Total Current Assets | 43.55K | 1.51M |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 0 | 257.62M |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 57K | 0 |
| Total Non-current Assets | 57K | 257.62M |
| Total Assets | 100.55K | 259.13M |
| Account Payables | 0 | 695.95K |
| Short-term Debt | 123.3K | 988.48K |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | (123.3K) | 0 |
| Total Current Liabilities | 43.08K | 1.68M |
| Long-term Debt | 123.3K | 0 |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 0 | 10.6M |
| Total Non-current Liabilities | 123.3K | 10.6M |
| Total Liabilities | 166.38K | 12.28M |
| Common Stock | 767 | 257.62M |
| Retained Earnings | (90.83K) | (10.78M) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | (65.83K) | 246.84M |
| Total Debt | 123.3K | 988.48K |
| Net Debt | 97.91K | 781.37K |
Soulpower Acquisition Corp.
NYSE:SOUL
Intrinsic Alpha fair value
Locked
Current Price
$10.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.